Current state of technologies and recognition of anti-SSA/Ro antibodies in China: A multi-center study.

Chen YL, Hu CJ, Peng LY, Wang CH, Zhao Y, Zhang W, Liu DZ, Chinese Sjögren's Syndrome Collaborative Research Group

Open source

DOI
10.1002/jcla.24045
Published
2021 Dec
Container
Journal of clinical laboratory analysis
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/jcla.24045,
  title = {Current state of technologies and recognition of anti-SSA/Ro antibodies in China: A multi-center study.},
  author = {Chen YL and Hu CJ and Peng LY and Wang CH and Zhao Y and Zhang W and Liu DZ and Chinese Sjögren's Syndrome Collaborative Research Group},
  year = {2021},
  journal = {Journal of clinical laboratory analysis},
  doi = {10.1002/jcla.24045},
  url = {https://doi.org/10.1002/jcla.24045}
}

RIS

TY  - JOUR
TI  - Current state of technologies and recognition of anti-SSA/Ro antibodies in China: A multi-center study.
AU  - Chen YL
AU  - Hu CJ
AU  - Peng LY
AU  - Wang CH
AU  - Zhao Y
AU  - Zhang W
AU  - Liu DZ
AU  - Chinese Sjögren's Syndrome Collaborative Research Group
PY  - 2021
JO  - Journal of clinical laboratory analysis
DO  - 10.1002/jcla.24045
UR  - https://doi.org/10.1002/jcla.24045
ER  - 

APA

YL, C., CJ, H., LY, P., CH, W., Y, Z., W, Z., DZ, L., & Group, C. S. S. C. R. (2021). Current state of technologies and recognition of anti-SSA/Ro antibodies in China: A multi-center study.. Journal of clinical laboratory analysis. https://doi.org/10.1002/jcla.24045

Source records